CAS No |
Product Name |
Molecular Formula |
1616703-93-5
|
Ticagrelor EP Impurity C;2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate
|
C25H30F2N6O5S
|
1616761-00-2
|
(3R,4R)-3-((2-Chloro-7H-pyrrolo(2,3-d)pyrimidin-4-yl)methylamino)-4-methyl-beta-oxo-1-piperidinepropanenitrile
|
C16H19ClN6O
|
1616967-26-0
|
Formoterol EP Impurity E;N-(2-hydroxy-5-(1-hydroxy-2-((2-(4-methoxy-3-methylphenyl)-1-methylethyl)amino)ethyl)phenyl)formamide
|
C20H26N2O4
|
1616979-93-1
|
tert-Butylbis(3,5-di-tert-butylphenyl)phosphine
|
C32H51P
|
1618657-31-0
|
Ezetimibe Impurity 9;Xxzjuzxkbfupqh-ikggrygdsa-N; (2R,3R,6S)-6-(4-fluorophenyl)-2-(4-hydroxyphenyl)oxane-3-carboxylic acid
|
C18H17FO4
|
1619994-68-1
|
1-(1-(2-(Methylsulfonyl)phenyl)-7-propoxy-3-indolizinyl)ethanone
|
C20H21NO4S
|
1619994-69-2
|
Ethyl (3-methyl-6-(4-methyl-3-(methylsulfonamido)phenyl)-(1,2,4)triazolo(4,3-b)pyridazin-8-yl)carbamate
|
C17H20N6O4S
|
1620097-06-4
|
(5R)-Hexahydro-5-methyl-1-(phenylmethyl)-1H-1,4-diazepine
|
C13H20N2
|
1620401-82-2
|
6,7-Dimethoxy-2-(1-pyrrolidinyl)-N-(5-(1-pyrrolidinyl)pentyl)-4-quinazolinamine
|
C23H35N5O2
|
1620458-09-4
|
Zoliflodacin;(4'R,6'S,7'S)-17'-fluoro-4',6'-dimethyl-13'-((4S)-4-methyl-2-oxo-1,3-oxazolidin-3-yl)spiro(1,3-diazinane-5,8'-5,15-dioxa-2,14-diazatetracyclo(8.7.0.02,7.012,16)heptadeca-1(17),10,12(16),13-tetraene)-2,4,6-trione
|
C22H22FN5O7
|
1620576-64-8
|
1-(4-(5-(5-Amino-6-(5-tert-butyl-1,3,4-oxadiazol-2-yl)pyrazin-2-yl)-1-ethyl-1H-1,2,4-triazol-3-yl)piperidin-1-yl)-3-hydroxypropan-1-one
|
C22H31N9O3
|
1621085-33-3
|
3-Methyl-N-((phenylmethoxy)carbonyl)-L-valine compd. with 2-propanamine
|
C14H19NO4.C3H9N
|
1621175-65-2
|
N-(3-Chloro-4-(((2-(methylamino)-6-(2-pyridinyl)-4-pyrimidinyl)amino)methyl)phenyl)methanesulfonamide
|
C18H19ClN6O2S
|
1621274-17-6
|
DPPF Pd G4;(SP-4-3)-(1-(Diphenylphosphino-?P)-1'-(diphenylphosphino)ferrocene)(methanesulfonato-?O)(2'-(methylamino-?N)(1,1'-biphenyl)-2-yl-?C)palladium
|
C48H43FeNO3P2PdS
|
1621274-19-8
|
(SP-4-3)-((5-(diphenylphosphino)-9,9-dimethyl-9H-xanthen-4-yl)diphenylphosphine-κP)(methanesulfonato-κO)(2'-(methylamino-κN)(1,1'-biphenyl)-2-yl-κC)-Palladium;XantPhos Pd G4
|
C53H47NO4P2PdS
|
1621681-63-7
|
Cabozantinib N-oxide;1-N-(4-(6,7-dimethoxy-1-oxidoquinolin-1-ium-4-yl)oxyphenyl)-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide
|
C28H24FN3O6
|
1622008-73-4
|
4,4'-(2,3-Dihydrothieno(3,4-b)-1,4-dioxin-5,7-diyl)bis(N,N-bis(4-methoxyphenyl)-benzenamine)
|
C46H40N2O6S
|
1622173-72-1
|
Cinacalcet Impurity 50 HCl;N-(1-(7,8-dihydronaphthalen-1-yl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine hydrochloride
|
C22H25ClF3N
|
1622848-92-3
|
(S)-5-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo(b)(1,4)oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide;3-(Phenylmethyl)-N-((3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl)-1H-1,2,4-triazole-5-carboxamide
|
C20H19N5O3
|
1622849-58-4
|
5-(Phenylmethyl)-N-((3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl)-3-isoxazolecarboxamide
|
C21H19N3O4
|
1622921-15-6
|
4-(2-(2-Cyclopentylidenehydrazinyl)-4-thiazolyl)benzonitrile hydrobromide
|
C15H14N4S.HBr
|
1622928-68-0
|
1-Methoxy-4-oxocyclohexane-1-carboxylic acid
|
C8H12O4
|
1623101-11-0
|
3-Chloro-N-(3-chloro-4-(4-chloro-1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)phenyl)-2-pyridinecarboxamide
|
C20H10Cl3N3O3
|
1624117-53-8
|
N-2-Naphthalenyl-N'-(2-oxo-2-(1-pyrrolidinyl)ethyl)urea
|
C17H19N3O2
|
1624294-38-7
|
N-(3-Ethenylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride (1:1)
|
C22H25N3O4.HCl
|
1624602-30-7
|
7-Chloro-4-(4-((2,4-dinitrophenyl)sulfonyl)-1-piperazinyl)quinoline
|
C19H16ClN5O6S
|
1624970-54-2
|
4',4''',4''''',4'''''''-(1,2-Ethenediylidene)tetrakis(1,1'-biphenyl)-4-carboxaldehyde
|
C54H36O4
|
1626387-80-1
|
(2R)-2,4-Dimethyl-1-piperazinecarboxylic acid 4-((3-chloro-2-fluorophenyl)amino)-7-methoxy-6-quinazolinyl ester
|
C22H23ClFN5O3
|
1627091-47-7
|
MLi-2-Bio-X;(2R,6S)-2,6-dimethyl-4-(6-(5-(1-methylcyclopropyl)oxy-1H-indazol-3-yl)pyrimidin-4-yl)morpholine
|
C21H25N5O2
|
1627494-13-6
|
8-((1R)-1-((3,5-Difluorophenyl)amino)ethyl)-N,N-dimethyl-2-(4-morpholinyl)-4-oxo-4H-1-benzopyran-6-carboxamide;AZD 8186
|
C24H25F2N3O4
|
1627503-67-6
|
1-(4-(6-Methyl-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl)phenyl)piperazine
|
C25H29N3O3
|
1627676-59-8
|
8-Fluoro-1,2,3,4-tetrahydro-N-((1R)-2-oxo-2-(1-pyrrolidinyl)-1-((3-(trifluoromethyl)phenyl)methyl)ethyl)-6-isoquinolinesulfonamide
|
C23H25F4N3O3S
|
1627696-51-8
|
(3R)-3-(5-Fluoro-4-pyrimidinyl)-2,3-dihydro-3-methyl-6-(1H-pyrazol-4-yl)-1H-isoindol-1-one
|
C16H12FN5O
|
1627710-50-2
|
2,6-Difluoro-4-(4-(4-(4-methyl-1-piperazinyl)phenyl)-3-pyridinyl)phenol
|
C22H21F2N3O
|
1627824-09-2
|
N-((R)-(2,3,4,5,6-Pentafluorophenoxy)phenoxyphosphinyl)-D-alanine 1-methylethyl ester
|
C18H17F5NO5P
|
1627917-17-2
|
Benzo(b)naphtho(2,3-d)furan-2-ylboronic acid
|
C16H11BO3
|
1627929-55-8
|
PLX51107;(S)-4-(6-(3,5-dimethylisoxazol-4-yl)-1-(1-(pyridin-2-yl)ethyl)-1H-pyrrolo(3,2-b)pyridin-3-yl)benzoic acid
|
C26H22N4O3
|
1628047-84-6
|
4-Bromo-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzoic acid 1,1-dimethylethyl ester;tert-butyl 4-bromo-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzoate
|
C18H17BrN2O3
|
1628047-87-9
|
1-((2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl)methyl)piperazine dihydrochloride;1-((4'-Chloro-5,5-dimethyl-3,4,5,6-tetrahydro-(1,1'-biphenyl)-2-yl)methyl)piperazine dihydrochloride
|
C19H27ClN2.2(HCl)
|
1628208-23-0
|
4,7-Dihydro-6-(1-methylethyl)-7-oxo-5-phenylpyrazolo(1,5-a)pyrimidine-3-carbonitrile;CPI 455
|
C16H14N4O
|
1628260-79-6
|
2-((2-Ethyl-6-(4-(2-(3-hydroxy-1-azetidinyl)-2-oxoethyl)-1-piperazinyl)-8-methylimidazo(1,2-a)pyridin-3-yl)methylamino)-4-(4-fluorophenyl)-5-thiazolecarbonitrile
|
C30H33FN8O2S
|
1628265-17-7
|
2-Chloro-4-(4-fluorophenyl)thiazole-5-carbonitrile
|
C10H4ClFN2S
|
1628316-74-4
|
5-((4-((6-(2,2,2-Trifluoroethyl)thieno(2,3-d)pyrimidin-4-yl)amino)-1-piperidinyl)methyl)-1H-indole-2-carbonitrile;MI 136
|
C23H21F3N6S
|
1628317-18-9
|
4-Methyl-5-((4-((6-(2,2,2-trifluoroethyl)thieno(2,3-d)pyrimidin-4-yl)amino)-1-piperidinyl)methyl)-1H-indole-2-carbonitrile;MI 463
|
C24H23F3N6S
|
1628431-65-1
|
4-Amino-2-cyanobenzoic acid methyl ester
|
C9H8N2O2
|
1628639-06-4
|
Olopatadine USP Related Compound A;Alpha-Hydroxy Olopatadine; (Z)-2-(11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenzo(b,e)oxepin-2-yl)-2-hydroxyacetic acid
|
C21H23NO4
|
1628732-62-6
|
Olinciguat;(2R)-3,3,3-trifluoro-2-(((5-fluoro-2-(1-((2-fluorophenyl)methyl)-5-(1,2-oxazol-3-yl)pyrazol-3-yl)pyrimidin-4-yl)amino)methyl)-2-hydroxypropanamide
|
C21H16F5N7O3
|
1628790-37-3
|
Cy5.5 alkyne;6-(1,1-dimethyl-2-(5-(1,1,3-trimethylbenzo(e)indol-3-ium-2-yl)penta-2,4-dienylidene)benzo(e)indol-3-yl)-N-prop-2-ynylhexanamide chloride
|
C43H46ClN3O
|
1628838-42-5
|
N-(2-Methyl-5'-(4-morpholinyl)-6'-((tetrahydro-2H-pyran-4-yl)oxy)(3,3'-bipyridin)-5-yl)-3-(trifluoromethyl)benzamide
|
C28H29F3N4O4
|
1629229-37-3
|
Fezolinetant;(4-fluorophenyl)-((8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-(1,2,4)triazolo(4,3-a)pyrazin-7-yl)methanone
|
C16H15FN6OS
|